← Back to all products
Retatrutide

Retatrutide

10mg/vial · Triple GIP/GLP-1/Glucagon Agonist

฿2,500
LINEWhatsApp
Purity >98%Keep RefrigeratedResearch Use Only

About this peptide

Retatrutide is a next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 clinical trials demonstrated up to 24.2% mean body weight reduction at 48 weeks — the highest efficacy reported among investigational peptides.The glucagon receptor component adds direct hepatic fat oxidation, making it uniquely potent for metabolic research.

⚠️ For research use only.

Frequently Asked Questions